Exploring the indirect effects of catechol-O-methyltransferase (COMT) genotype on psychotic experiences through cognitive function and anxiety disorders in a large birth cohort of children

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 5, 2014, Pages 410-420

  Niarchou, Maria ^a   Zammit, Stanley ^a   Escott Price, Valentina ^a   Owen, Michael J ^a   van den Bree, Marianne B M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ALSPAC; Attention; Children; COMT; Processing speed; Psychotic experiences

Indexed keywords

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN;

ALLELE; ANXIETY DISORDER; ARTICLE; CHILD; CHILDHOOD DISEASE; COGNITION; ENDOPHENOTYPE; HAPLOTYPE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTIC EXPERIENCE; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INFANT; LONGITUDINAL STUDY; MALE; PHYSIOLOGY; RISK;

ANXIETY DISORDERS; CATECHOL O-METHYLTRANSFERASE; CHILD; COGNITION; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RISK;

EID: 84903699903     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32245     Document Type: Article

References (78)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. 2003. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23(6):2008-2013.
2. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7):827-834.
3. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O'Donovan MC, Niculescu AB. 2012. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Mol Psychiatry 17(9):887-905.
4. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D. 2004. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42(4):653-663.
5. Barch DM, Ceaser A. 2012. Cognition in schizophrenia: Core psychological and neural mechanisms. Trends in Cognitive Sciences 16(1):27-34.
6. Barnett JH, Heron J, Goldman D, Jones PB, Xu K. 2009. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry 166(8):909-916.
7. Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K, Jones PB. 2007a. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 164(1):142-149.
8. Barnett JH, Jones PB, Robbins TW, Muller U. 2007b. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 12(5):502-509.
9. Barnett JH, Scoriels L, Munafo MR. 2008. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 64(2):137-144.
10. Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, Robertson IH, Gill M. 2005. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 163(3):352-360.
11. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, Nardini M, Weinberger DR, Dallapiccola B. 2006. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26(15):3918-3922.
12. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Kunz M, Chakos M, Cooper TB, Lieberman JA. 2002. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52(7):701-707.
13. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, Molloy L, Ness A, Ring S, Davey Smith G. 2012. Cohort profile: The 'children of the 90s'-The index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 42(1):111-127.
14. Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK. 2007. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 9(4):370-376.
15. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, Munafo MR. 2013. Power failure: Why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14(5):365-376.
16. Caldú X, Vendrell P, Bartrés-Faz D, Clemente I, Bargalló N, Jurado MÁ, Serra-Grabulosa JM, Junqué C. 2007. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. NeuroImage 37(4):1437-1444.
17. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5):807-821.
18. Christ SE, White DA, Mandernach T, Keys BA. 2001. Inhibitory control across the life span. Dev Neuropsychol 20(3):653-669.
19. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE. 1991. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11(7):1907-1917.
20. De Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG. 2004. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 34(5):533-539.
21. Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR. 2008. Genetic variation in catechol-O-methyltransferase: Effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 63(1):72-79.
22. Dickinson D, Elvevåg B. 2009. Genes, cognition and brain through a COMT lens. Neuroscience 164(1):72-87.
23. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Heredity 66:11.
24. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98(12):6917-6922.
25. Fisher HL, Schreier A, Zammit S, Maughan B, Munafò MR, Lewis G, Wolke D. 2012. Pathways between childhood victimization and psychosis-like symptoms in the ALSPAC birth cohort. Schizophr Bull.
26. Fletcher PC, Frith CD. 2009. Perceiving is believing: A Bayesian approach to explaining the positive symptoms of schizophrenia. Nat Rev Neurosci 10(1):48-58.
27. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, Henderson J, Macleod J, Molloy L, Ness A, Ring S, Nelson SM, Lawlor DA. 2012. Cohort profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 42(1):97-110.
28. Fry AF, Hale S. 1996. Processing speed, working memory, and fluid intelligence: Evidence for a developmental cascade. Psychol Sci 7(4):237-241.
29. Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, Rossi A, Pini S, Vita A, Cassano P, Stratta P, Severino G, Del Zompo M. 2005. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: Associations with cognitive and motor impairment. Neuropsychobiology 52(2):83-89.
30. Gaysina D, Xu MK, Barnett JH, Croudace TJ, Wong A, Richards M, Jones PB. 2013. The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence. Biol Psychol 92(2):359-364.
31. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. 2002. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry 159(8):1395-1402.
32. Goldman-Rakic PS, Lidow MS, Gallager DW. 1990. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci 10(7):2125-2138.
33. Goldman D, Oroszi G, Ducci F. 2005. The genetics of addictions: Uncovering the genes. Nat Rev Genet 6(7):521-532.
34. Goodman A, Heiervang E, Collishaw S, Goodman R. 2011. The "DAWBA bands" as an ordered-categorical measure of child mental health: Description and validation in British and Norwegian samples. Social Psychiatry Psychiatr Epidemiol 46(6):521-532.
35. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. 2000. The development and well-being assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 41(5):645-655.
36. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW. 2000. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20(3):1208-1215.
37. Han DH, Kee BS, Min KJ, Lee YS, Na C, Park DB, Lyoo IK. 2006. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 17(1):95-99.
38. Hayes AF. 2009. Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Commun Monogr 76(4):408-420.
39. Honey GD, Suckling J, Zelaya F, Long C, Routledge C, Jackson S, Ng V, Fletcher PC, Williams SCR, Brown J, Bullmore ET. 2003. Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain 126(8):1767-1781.
40. Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, Hollis C, Lewis G, Menezes P, Thompson A, Wolke D, Zammit S, Harrison G. 2008. IQ and non-clinical psychotic symptoms in 12-year-olds: Results from the ALSPAC birth cohort. Br J Psychiatry 193(3):185-191.
41. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, Benkelfat C, Labelle A. 2002. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 59(7):662-663.
42. Karoum F, Chrapusta SJ, Egan MF. 1994. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63(3):972-979.
43. Khandaker GM, Barnett JH, White IR, Jones PB. 2011. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res 132(2-3):220-227.
44. Kirrane RM, Mitropoulou V, Nunn M, New AS, Harvey PD, Schopick F, Silverman J, Siever LJ. 2000. Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder. Neuropsychopharmacology 22(1):14-18.
45. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3):243-250.
46. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13):4202-4210.
47. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. 2002. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7(1):83-104.
48. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159(4):652-654.
49. McAuley T, White DA. 2011. A latent variables examination of processing speed, response inhibition, and working memory during typical development. J Exp Child Psychol 108(3):453-468.
50. McCarthy G, Blamire AM, Puce A, Nobre AC, Bloch G, Hyder F, Goldman-Rakic P, Shulman RG. 1994. Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc Natl Acad Sci USA 91(18):8690-8694.
51. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I. 2004. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 161(9):1703-1705.
52. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. 2006. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 11(9):867-877, 797.
53. Mier D, Kirsch P, Meyer-Lindenberg A. 2010. Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis. Mol Psychiatry 15(9):918-927.
54. Minzenberg MJ, Xu K, Mitropoulou V, Harvey PD, Finch T, Flory JD, New AS, Goldman D, Siever LJ. 2006. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Psychiatr Genet 16(3):117-124.
55. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807):1930-1933.
56. Niarchou M, Zammit S, Walters J, Lewis G, Owen MJ, van den Bree MB. 2013. Defective processing speed and nonclinical psychotic experiences in children: Longitudinal analyses in a large birth cohort. Am J Psychiatry 170(5):550-557.
57. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K. 1998. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80(2):145-148.
58. Polanczyk G, Moffitt TE, Arseneault L, Cannon M, Ambler A, Keefe RSE, Houts R, Odgers CL, Caspi A. 2010. Etiological and clinical features of childhood psychotic symptoms: Results from a birth cohort. Arch Gen Psychiatry 67(4):328-338.
59. Pooley EC, Fineberg N, Harrison PJ. 2007. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: Case-control study and meta-analysis. Mol Psychiatry 12(6):556-561.
60. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. 2000. Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry 57(11):1053-1058.
61. Purcell S. 2013. PLINK software (version 1.07). Retrieved from: http://pngu.mgh.harvard.edu/purcell/plink/.
62. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
63. Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I. 1996. The structure of normal human attention: The test of everyday attention. J Int Neuropsychol Soc 2:12.
64. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L. 2004. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161(6):1110-1112.
65. Rucker DD, Preacher KJ, Tormala ZL, Petty RE. 2011. Mediation analysis in social psychology: Current practices and new recommendations. Soc Personality Psychol Compass 5(6):359-371.
66. Sokolowski JD, Salamone JD. 1994. Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res 642(1-2):20-28.
67. Stefanis NC, Van Os J, Avramopoulos D, Smyrnis N, Evdokimidis I, Hantoumi I, Stefanis CN. 2004. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: A population study in 543 young men. Biol Psychiatry 56(7):510-515.
68. Tsai S-J, Yu YWY, Chen T-J, Chen J-Y, Liou Y-J, Chen M-C, Hong C-J. 2003. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 338(2):123-126.
69. Wang Y, Li J, Chen C, Chen C, Zhu B, Moysis RK, Lei X, Li H, Liu Q, Xiu D, Liu B, Chen W, Xue G, Dong Q. 2013. COMT rs4680 Met is not always the 'smart allele': Val allele is associated with better working memory and larger hippocampal volume in healthy Chinese. Genes Brain Behav 12(3):323-329.
70. Wardle MC, de Wit H, Penton-Voak I, Lewis G, Munafo MR. 2013. Lack of association between COMT and working memory in a population-based cohort of healthy young adults. Neuropsychopharmacology 38(7):1253-1263.
71. Wechsler D, Golombok S, Rust J. 1992. WISC-III Wechsler Intelligence Scale for Children-3rd Edition UK Manual. Sidcup, UK: The Psychological Corporation.
72. Wigman JTW, van Nierop M, Vollebergh WAM, Lieb R, Beesdo-Baum K, Wittchen H-U, van Os J. 2012. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity-Implications for diagnosis and ultra-high risk research. Schizophr Bull 38(2):247-257.
73. Williams D, Tijssen M, van Bruggen G, Bosch A, Insola A, Lazzaro VD, Mazzone P, Oliviero A, Quartarone A, Speelman H, Brown P. 2002. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 125(7):1558-1569.
74. Williams HJ, Owen MJ, O'Donovan MC. 2007. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull 33(3):635-641.
75. Woo JM, Yoon KS, Yu BH. 2002. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 159(10):1785-1787.
76. Zhao X, Lynch JG Jr, Chen Q. 2010. Reconsidering Baron and Kenny: Myths and truths about mediation analysis. J Consum Res 37(2):197-206.
77. Zammit S, Hamshere M, Dwyer S, Georgiva L, Timpson N, Moskvina V, et al. 2013. A population-based study of genetic variation and psychotic experiences in adolescents. Schizophrenia bulletin sbt146.
78. Zammit S, Owen MJ, Evans J, Heron J, Lewis G. 2011. Cannabis, COMT and psychotic experiences. Br J Psychiatry 199(5):380-385.